There is always the possibility that POH have another patch or 2 about to enter the clinic.
Due to the platform nature of the patch and TPM, at least in the case of opiods, it requires very little if any variation for the different drugs.
Whats to say a Fentanyl patch isnt to come soon for example?
Having said that, Im sure the oxymorphone was a very strategic decision based on feedback from the pharmas, however if POH needle all the majors in their product pocket..........can POH be ignored. I doubt it.
oxymorphone trials begin, page-32
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $11.50K | 4.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 101422109 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20872825 | 7 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |